bpc-157 tb-500 stack protocol Wolverine Peptide Therapy (BPC-157 + TB-500) BPC-157 & TB-500 Wolverine Stack
Description
Daily subcutaneous or intramuscular injection, ~300-500 mcg/day in standard use
Local inhibitory network GIPR-expressing neurons in the dorsal vagal complex (AP/NTS) are predominantly GABAergic with Gad1/Gad2 co-expression
Published and grant pending
This product is provided in a capsule-based oral research format for laboratory investigation and comparative research applications
The Paris Fire Brigade reported that between 1995 and 2003, there was a 41.7% survival rate for 72 patients exposed to cyanide-poisoning through smoke inhalation, and within this group 9 of the the 12 patients with increased systolic blood pressure (bp) treated with hydroxocobalamin demonstrated a recovery of systolic bp to normal (Fortin, 2006)
